TSPO Antibody - #DF8227

Figure 6 Histological and western blot analyses confirm the temporal changes of tissue FAP levels during AAA progression. A) The outcomes of H&E, EVG, Masson blue staining, and immunohistochemical examinations of TSPO and vimentin of specimens from the indicated groups of New Zealand rabbits. B) The medial thickness of aortic specimens from the indicated groups of New Zealand rabbits. C,D) Immunofluorescence analysis (C) and its quantification (D) of TSPO (green) from the indicated groups of New Zealand rabbits. E) Immunofluorescence analysis, investigating the co-expression of FAP and α-SMA, among the indicated groups of New Zealand rabbits. F) Co-localization analysis of FAP and α-SMA in the medial layer of the aorta among the indicated groups of New Zealand rabbits. The red line indicated α-SMA expression, while the green line represented FAP expression. G,H) The western blot of FAP, OPN, and α-SMA (G) and its quantification (H) in the indicated groups of New Zealand rabbits. *p < 0.05, **p < 0.01, and ***p < 0.001, ns, not statistically significant. TSPO, Translocator protein.

Figure 5. Immunohistochemical results of TSPO, Iba-1, NLRP3 expression (Under 40× optical microscope). Brown cells are positive (as shown by the black arrow) and blue cells are negative.